Element Biosciences: Funding, Investors & Team (Sep 2026)
Element Biosciences is a biotech company specializing in creating new genetic analysis tools. They are working on a customizable DNA sequencing platform that will offer top-notch data quality, flexibility in workflow, and greater accessibility to advanced sequencing technology. Utilizing their unique methods to enhance signal clarity, the company is able to bring about major advancements in surface chemistry, instrumentation, and biochemistry which significantly reduce costs and improve data quality in DNA sequencing.
Element Biosciences has raised $277M across 2 funding rounds on record, the most recent a Series E announced in Jun 2026.
Element Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Element Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Element Biosciences raised $277M in a Series D announced in Jul 2024.
1.9 years later, a Series E was announced in Jun 2026 with no disclosed amount.
Element Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Element Biosciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Element Biosciences in Biotechnology and San Diego
Companies Similar to Element Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Element Biosciences Funding FAQs
What does Element Biosciences do?
Element Biosciences is a biotech company specializing in creating new genetic analysis tools. They are working on a customizable DNA sequencing platform that will offer top-notch data quality, flexibility in workflow, and greater accessibility to advanced sequencing technology. Utilizing their unique methods to enhance signal clarity, the company is able to bring about major advancements in surface chemistry, instrumentation, and biochemistry which significantly reduce costs and improve data quality in DNA sequencing.
How much funding has Element Biosciences raised?
Element Biosciences has raised $277M across 2 rounds on record.
When did Element Biosciences last raise funding?
Element Biosciences' most recent funding round on record was announced in Jun 2026. The amount was not disclosed.
Who founded Element Biosciences?
FundedIQ lists Molly He (Founder) at Element Biosciences.
Where is Element Biosciences headquartered?
Element Biosciences is based in San Diego, California, United States.
How many employees does Element Biosciences have?
Element Biosciences is in the 251-500 employee band.
About FundedIQ's Element Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Element Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.